bharat biotech’s covaxin gets nod for phase 2/3 trials on 2-18 years old | latest english news
Published 3 years ago • 11K plays • Length 3:25Download video MP4
Download video MP3
Similar videos
-
4:05
covaxin gets nod for phase 2/3 trials on 2-18 year-olds: why it is significant
-
2:18
bharat biotech’s 'covaxin' gets sec nod for phase 2-3 clinical trials on 2 to 18 year-olds
-
2:16
bharat biotech’s 'covaxin' gets dcgi nod for phase 2, 3 clinical trials on children aged 2 to 18 yrs
-
1:01
bharat biotech’s ‘covaxin’ gets nod by sec for phase 2, 3 trials on 2 to 18 yrs
-
3:52
bharat biotech's covaxin recommended by expert panel for phase 2/3 trials on children
-
48:39
bharat biotech's dr krishna ella on efficacy of covaxin, side effects & nasal vaccine | newstrack
-
3:58
major breakthrough in covid-19 treatment, bharat biotech's covaxin vaccine gets nod for human trials
-
3:13
india's 1st mpox rt-pcr kit | andhra pradesh medtech zone | monkeypox
-
0:50
covaxin for kids: bharat biotech completes phase 2/3 trials, to submit data to dcgi next week
-
3:04
coronavirus vaccine | covaxin recommended for next phase of trials for 2-18 age group: report
-
1:07
dcgi approves phase 2, 3 trials of ‘covaxin’ on 2 to 18 year-olds
-
1:25
india's first indigenous vaccine 'covaxin' gets expert panel's nod | bharat biotech | world news
-
0:45
coronavirus vaccine news | covaxin's phase 2 and 3 trials for kids soon, expert panel gives nod
-
4:50
covid-19 vaccine for kids | covaxin gets approval for phase 2-3 clinical trials for 2-18 age group
-
1:42
covid-19 updates: bharat biotech completes phase 2/3 trials of covaxin for children
-
1:06
bharat biotech will begin clinical trial of covaxin on 2-18 age group
-
1:30
covaxin safe, well-tolerated in 2-18 years age-group: bharat biotech
-
4:08
vaccine for children: bharat biotech's covaxin gets the nod for pediatric use
-
2:41
covid-19: bharat biotech's covaxin gets nod for phase three trial; 22,000 volunteers enrolled
-
0:54
expert panels recommend bharat biotech's covaxin for phase 2/3 trials on 2-18 year-olds
-
4:00
covaxin for kids: sec approves bharat biotech's covid vaccine for children from 2 to 18 yrs
-
0:40
bharat biotech's covaxin goes for who nod tomorrow | breaking news | india today